Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: ZTS

Zoetis Inc.

Healthcare | Drug Manufacturers - General
$74.80 -39.26 (-34.42%) as of 2026-07-15 04:51 UTC
Market Cap$31.4B
Volume2.89M
EPS (TTM)$6.02

Zoetis Inc. (NYSE: ZTS) is a $31.4B drug manufacturers - general company trading at $74.80 (−34.4% today) — 12.4× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-15 04:51 UTC.

52-Week Range
Low $72.91High $123.32

What Zoetis Inc. does

The company manufactures and distributes animal health products sold in more than 100 countries, with some products produced at sole-source manufacturing sites where minor deviations can cause delays or recalls. The company's success depends on maintaining customer perceptions of product quality and safety, which contribute to brand loyalty even after patent protection expires. Revenue is significantly exposed to foreign currency fluctuations, with a substantial portion earned outside the U.S. dollar.

Summarized from Zoetis Inc.’s SEC filings · Read the filing ↗

Key facts
Quote
Price$74.80
Change (1D)-39.26 (-34.42%)
Market cap$31.4B
Volume2.89M shares
52-week range$72.91 – $123.32
Valuation
P/E (TTM)12.43×
EPS (TTM)$6.02
Price/book9.41×
Return on equity80.25%
Debt/equity2.71
Returns
52-week return+2.6%
Revenue Trend
FY2021: $7.78B$7.78BFY2021FY2022: $8.08B$8.08BFY2022FY2023: $8.54B$8.54BFY2023FY2024: $9.26B$9.26BFY2024FY2025: $9.47B$9.47BFY2025
Annual Revenue · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-22
  • 2026-06-22Stetter MarkA317$25.0K
  • 2026-06-11MCCALLISTER MICHAEL BG-1,209—
  • 2026-05-26Stetter MarkM-1,572—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC47,778,909$6.01B+12.9%
  • BlackRock, Inc.30,933,939$3.66B-17.2%
  • VANGUARD CAPITAL MANAGEMENT LLC26,072,846$3.08BNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Zoetis Inc. do?

The company manufactures and distributes animal health products sold in more than 100 countries, with some products produced at sole-source manufacturing sites where minor deviations can cause delays or recalls.

What is ZTS's valuation?

ZTS trades at $74.80, 12.43× trailing earnings, as of 2026-07-15.

When did ZTS last file with the SEC?

Zoetis Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-22. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-15 04:51 UTC. This page is also available as JSON at /api/data?ticker=ZTS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ZTS and 3,500+ tickers.

Create a free account — keep ZTS
For your agent
GET /api/data?ticker=ZTS

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt